Artifactual Sequence Chimera¶
An assay-generated nucleic-acid molecule joining contiguous sequence regions from distinct input templates into one product.
Core Idea¶
An artifactual sequence chimera is one nucleic-acid molecule synthesized during an assay whose contiguous sequence regions come from distinct input templates. The combined molecule was not an intact input parent. A later sequencing read can reveal the molecule, but is evidence rather than the object being defined. Reverse transcription and PCR supply two experimentally documented production settings, without proving one universal joining mechanism or rate.[ref-fe7fbcb1f38b][ref-066a7d334e56]
Scope of Application¶
The entry concerns composite nucleic-acid products made during laboratory synthesis from different input molecules. Ouhammouch and Brody report AMV reverse transcriptase switching between RNA templates to make chimeric cDNA in vitro. Omelina and colleagues identify cross-parent barcode–region-of-interest DNA products after mixed-template PCR of two known plasmids. The first study's homology and temperature findings apply to its tested conditions; the second study's rates and PCR optimization belong to its own assays.[ref-fe7fbcb1f38b][ref-066a7d334e56]
A natural fusion, genomic rearrangement, or deliberately prebuilt hybrid input is not an artifact of this assay merely because it contains parts of different origins. Nor is every surprising alignment proof of laboratory joining.[^ref-066a7d334e56]
Clarity¶
Track distinct source templates → synthesis workflow → one composite molecule → provenance evidence. Two separate parent molecules in one reaction are a mixture. A cross-parent sequence combination absent from either known input can establish a joined product when the test itself is controlled. A read that aligns to different references suggests a candidate, but by itself cannot establish when or where the join occurred; this last evidential caution is inferred from the controlled parental design.[^ref-066a7d334e56]
The product's artifactual origin and its possible misleading interpretation are different facts. A chimera remains a chimera if recognized before a false biological inference is made.[^ref-066a7d334e56]
Manages Complexity¶
Sequencing workflows can move from input templates to synthesized molecules to reads and finally to inferred biological variants or barcode–target pairings. Keeping those stages apart prevents a cross-parent laboratory product from being treated automatically as an intact biological parent. In the MPRA study, chimeric amplification products could confound genuine barcode–region-of-interest associations.[^ref-066a7d334e56]
An abundance-based filtering rule or one diagnostic PCR protocol may help a particular study, but neither is the definition of the molecule. Omelina's controlled diagnostic conditions also show why a test for chimeras must be checked for creating its own false signal.[^ref-066a7d334e56]
Abstract Reasoning¶
For a proposed case, identify the input molecules and which region of the product each supplied. Ask whether one contiguous molecule with the mixed combination was synthesized in the assay and whether the combination existed in any intact input. Check parent markers, controls, or other provenance evidence before assigning the join to laboratory synthesis. If only the two separate parents are present, or a fusion existed before the workflow, the named artifact has not been established.[ref-fe7fbcb1f38b][ref-066a7d334e56]
The shared relation is a one-product cross-template origin. The particular polymerase, temperature behavior, and detection primers are properties of individual experiments, not universal conditions.[ref-fe7fbcb1f38b][ref-066a7d334e56]
Knowledge Transfer¶
The same provenance test applies to the cited in-vitro reverse-transcription and mixed-template PCR cases despite different substrates and assay machinery. The AMV experiment's temperature finding does not become a PCR law, and the MPRA study's diagnostic primers do not become a general cDNA test. A wider “parts from different sources presented as one” pattern might invite a future Prime, but no present live direct parent was validated for this molecular identity.[ref-fe7fbcb1f38b][ref-066a7d334e56]
The current placement is an approved unparented root. Composition in the live catalog concerns aesthetic arrangement; Sequence Homology concerns ancestry; Mosaic Genetics concerns cell populations; De Novo Transcriptome Assembly is a workflow; and Nucleic Acid Secondary Structure concerns folding. None was shown to be a strict direct genus or prerequisite of both products.[ref-fe7fbcb1f38b][ref-066a7d334e56]
Example¶
Ouhammouch and Brody report chimeric cDNA produced when AMV reverse transcriptase switches between RNA templates in vitro. Mapped back: different RNAs are the source templates, reverse transcription is the synthesis workflow, the resulting cDNA is one composite molecule, and the experimental template-switch report supplies the provenance evidence. The reported temperature behavior is confined to the tested system.[^ref-fe7fbcb1f38b]
Omelina and colleagues amplified two plasmids with known barcode–target pairings and detected cross-parent combinations absent from either input under controlled diagnostic conditions. Mapped back: the plasmids are the sources, mixed-template PCR is the workflow, the cross-parent amplified DNA is one product, and known input pairings plus test controls provide provenance contrast. These are unlike assay realizations of the same molecular relation.[^ref-066a7d334e56]
Neighborhood in Abstraction Space¶
Artifactual Sequence Chimera sits in a sparse region of the domain-specific corpus (93rd percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Unclustered & Miscellaneous (2551 abstractions)
Nearest neighbors
- Epitope mapping — 0.80
- Surveyor Nuclease Assay — 0.80
- DNA Replication — 0.79
- Expression Cloning — 0.78
- Artificial gene synthesis — 0.78
Computed from structural-signature embeddings · 2026-10-08
Not to Be Confused With¶
A mixed sample contains separate parents, not one joined product. A natural fusion or genomic rearrangement predates the assay. A designed hybrid input can be copied without a new artifact. A chimeric-looking read is a possible observation, not proof of the molecule's laboratory origin. Cellular or organismal chimerism concerns populations of cells rather than this one synthesized molecule. A specific abundance filter or PCR diagnostic rule is a method, not the identity.[^ref-066a7d334e56]
References¶
[^ref-fe7fbcb1f38b]: Mohamed Ouhammouch and Edward N. Brody, “Temperature-dependent template switching during in vitro cDNA synthesis by the AMV-reverse transcriptase,” Nucleic Acids Research 20, no. 20 (1992), pp. 5443–5450, abstract. https://pmc.ncbi.nlm.nih.gov/articles/PMC334354/
[^ref-066a7d334e56]: Evgeniya S. Omelina et al., “Optimized PCR conditions minimizing the formation of chimeric DNA molecules from MPRA plasmid libraries,” BMC Genomics 20, supplement 7 (2019), article 536, Results, Figure 1b–d, Tables 1–2, and Discussion. https://pmc.ncbi.nlm.nih.gov/articles/PMC6620194/